trimethoprim has been researched along with Critical Illness in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, a population pharmacokinetic model using plasma data was built." | 1.56 | Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy. ( Bellmann, R; Bellmann-Weiler, R; Beyer, R; Broeker, A; Eschertzhuber, S; Gasperetti, T; Hotter, J; Joannidis, M; Lorenz, I; Ranke, P; Ströhle, M; Welte, R; Wicha, SG; Zaruba, MM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Welte, R | 1 |
| Beyer, R | 1 |
| Hotter, J | 1 |
| Broeker, A | 1 |
| Wicha, SG | 1 |
| Gasperetti, T | 1 |
| Ranke, P | 1 |
| Zaruba, MM | 1 |
| Lorenz, I | 1 |
| Eschertzhuber, S | 1 |
| Ströhle, M | 1 |
| Bellmann-Weiler, R | 1 |
| Joannidis, M | 1 |
| Bellmann, R | 1 |
| Tokatly Latzer, I | 1 |
| Nahum, E | 1 |
| Cavari, Y | 1 |
| Lazar, I | 1 |
| Ben-Ari, Y | 1 |
| Ben-Shimol, S | 1 |
| Ben-Shalom, G | 1 |
| Geffen, Y | 1 |
| Goldberg, L | 1 |
| Rubinstein, M | 1 |
| Keller, N | 1 |
| Pessach, IM | 1 |
| Paret, G | 1 |
2 other studies available for trimethoprim and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy.
Topics: Adult; Anti-Bacterial Agents; Continuous Renal Replacement Therapy; Critical Illness; Humans; Renal | 2020 |
Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Comorbidity; Critical Illness; Drug C | 2019 |